Patent · US Active

Pyrimidinyl tyrosine kinase inhibitors

US9394277B2 · kind B2 · utility

6Cited by

6References

26Claims

0Family size

Assignees

Biogen MA Inc. · US
Sunesis Pharmaceuticals, Inc. · US

Inventors

Brian T. Hopkins · Newton, US
Patrick R. Conlon · Wakefield, US
Timothy Chan · Cambridge, US
Tracy J. Jenkins · Watertown, US
Xiongwei Cai · Arlington, US
Michael Humora · Weston, US
Xianglin Shi · Newton, US
Ross A. Miller · Fanwood, US
Andrew Thompson

Key dates

Filing date	Jun 7, 2013
Grant date	Jul 19, 2016
Priority date	—
Expiry date	Jun 7, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.